Invokana is a prescription medication which is used to treat Diabetes. It is prescribed to patients who have difficulty regulating their blood sugar levels. Invokana is known as an SGLT2 inhibitor, which lowers blood sugar levels by causing the kidneys to remove sugar through the urine.
Invokana and other SGLT2 inhibitors are being investigated for causing a high risk of kidney failure and/or ketoacidosis. Ketoacidosis is an alteration of ketones, or acid levels, in the blood. It can result in loss of consciousness, diabetic coma, extended hospitalization, and even death. It can also cause kidney failure, which can result in electrolyte imbalances, poor blood pressure control, weakness, need for dialysis, abnormal heart rhythms, and sudden death.
If you were diagnosed with ketoacidosis within 15 days of last use, or experienced kidney failure within 45 days of last use of an SGLT2 inhibitor such as Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance, or Glyxambi, please contact our office for a free consultation today.